Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Alyssa Gilderhus was 18 when she suffered a brain aneurysm and entered Mayo Clinic in Rochester, Minnesota. Surgeons saved her life, but her parents were dissatisfied with her care in the rehabilitation unit and wanted her transferred.
A protein molecule in the blood could indicate whether a person will develop kidney cancer, according to a study published in Clinical Cancer Research.
When CMS announced it was changing the accountable care organization model to encourage more organizations to take on more financial risk, industry stakeholders had a lot to review in the 600-plus page proposed rule.
Writing letters to physicians who prescribe higher than average amount of a prescription drug has helped cut back, according to new research published in JAMA Psychiatry.
Researchers at the University of Utah Health have developed high-tech tools to uncover the genetic cause of early infantile epileptic encephalopathy (EIEE), according to a press release.
The Association of Black Cardiologists (ABC) announced the issuance of Prior Authorization (PA) Resource Kits designed specifically for cardiologists who work with underserved minority patients.
